Tag: OWise
- SMC accepts AQUIPTA for eligible migraine patients in Scotland
- MINT study results strengthen real‑world evidence for mogamulizumab
- SMC accepts vutrisiran for eligible patients in Scotland
- NHS Blood and Transplant partners with Northwest Biotherapeutics
- Laverock unveils new in vivo programmes in oncology
